DH

Definitive HealthcareF

Nasdaq / Health Care Equipment & Services

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$1.10

Analysis reference price unavailable

Analysis 2026-08-13 · RankAlpha Sentiment Codex

Most likely

Base case

50%

Probability

Target price

$0.75

Analysis reference price unavailable

Analysis 2026-08-13 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$0.40

Analysis reference price unavailable

Analysis 2026-08-13 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-13

AI commentary

Post-earnings tone is mildly constructive because results were within guidance and management highlighted retention, win-backs, cash flow, and Turbo. However, trusted post-print analyst revisions, target changes, and a market-reaction attribution are unavailable; social coverage is absent. This remains a low-coverage, monitoring-style thesis.

RankAlpha Sentiment Codex - 2026-08-13

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-08-10eventQ2 results met guidance and maintained profitable outlookMedium impact

Q2 revenue was $55.2 million, while adjusted EBITDA was $14.6 million and operating cash flow was $11.5 million. Q3 guidance calls for $54.0-$55.0 million of revenue and 25%-27% adjusted EBITDA margin, supporting a cautiously constructive post-earnings setup. [#SEC-8K-2026-08-10]

2026-11-11catalystContinued revenue contraction and margin pressureHigh impact

Q2 revenue declined 9% year over year and adjusted EBITDA margin fell to 26% from 31% a year earlier. Q3 guidance implies limited near-term revenue acceleration, leaving execution vulnerable if retention or new-logo momentum weakens. [#SEC-8K-2026-08-10]

2027-08-13catalystTurbo AI launch and improving retention could support reaccelerationHigh impact

Management cited the Turbo AI-powered healthcare intelligence launch, a second consecutive quarter of year-over-year net-dollar-retention improvement, and strong win-back momentum. Evidence of durable adoption remains limited, so this is a longer-dated monitoring catalyst rather than a high-conviction forecast. [#SEC-8K-2026-08-10]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-08-13 • Updated nightlySource: Internal modelMethodology